IMMUTOL
The 3rd Annual Meeting of IMMUTOL was hosted and organised by INN-Acta in Siena, Italy, between 20th and 21st of May 2026. The meeting provided a valuable opportunity for in-person discussions, sharing results, and planning…
read more
Jana Willemyns (IGTP) participated in the 46th Congress of the Spanish Society of Immunology (Sociedad Española de Inmunología, SEI), which took place in Cordoba, Spain, from April 16th to 18th,…
read more
Liubov Babii & Daniëlle ter Braake from SQ presented a poster at the NVVI conference in 2025, Noordwijkerhout, The Netherlands. The poster was focused on how VitD3DCIL-10 modulate B cell…
read more
Liubov Babii & Daniëlle ter Braake from SQ presented a poster at the Sanquin Science Day to show their data on the T cell-independent effect of VitD3DCIL-10 on B cells.…
read more
Alex Agúndez Moreno and Eva Martínez-Cáceres from IGTP represented IMMUTOL at the XIX Congress of the Catalan Society of Immunology, SCI 2025, 20-21st November 2025, Barcelona, Spain. LINK: https://sci.cat/?p=page/html/detallactivitat/id/27307/codi_entitat/022/tipus_entitat/s
read more
Attila Imre (SRI) presented a poster entitled: Early stage health economic evaluation of IMMUTOL gene Therapy for relapsing/remitting Multiple Sclerosis in the Netherlands at ISPOR Europe 2025, 9-12 November 2025,…
read more
Alex Agundez-Moreno and Eva Martínez-Cáceres from the IGTP team represented IMMUTOL at the meeting of the Federation of Clinical Immunology Societies (FOCIS) 2025, Rouen, France, 20-24th October 2025. Eva gave…
read more
41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held between September 24th–26th in Barcelona, Spain. IMMUTOL was represented by team members from the Institut de…
read more
Sara presented her work on the development of an advanced cell therapy based on antigen-specific tolerogenic dendritic cells (TolDCs) to re-establish immune tolerance in immune-mediated diseases. Event website
read more